Products

Our products with links to the regulator’s information for prescribing healthcare professionals and patients.

Alimera Product Portfolio

In compliance with regulations, we do not provide further information about our products on this website.

Our products are approved and regulated in the UK by the Medicines & Healthcare Products Regulations Agency (MHRA) for specific uses.  Product name, indication and availability may vary by country.

Reporting side effects

If you believe you have experienced any medical side effects from an Alimera Sciences product, please consult your physician or healthcare professional immediately.

Adverse events should always be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Alimera Sciences on pvalimerasciences@alimerasciences.com

Get in touch

UK Office

Alimera Sciences Ltd

Royal Pavilion, Wellesley Road, Aldershot, Hampshire, GU11 1PZ. United Kingdom

Product enquiries: +44 (0) 800 148 8274
General enquiries: +44 (0) 1252 354 000

Report an adverse event

If you believe you have experienced any medical side effects from an Alimera Sciences product, please consult your physician or healthcare professional immediately.
Adverse events should also be reported to Alimera Sciences: pvalimerasciences@alimerasciences.com

Report a compliance concern

You may report a compliance concern in any of the following ways, 24 hours a day, 7 days a week:

Website: www.lighthousegoto.com/AlimeraCompliance/eng
Telephone: First enter access code: 0-800-89-0011 (British Telecom) Then dial toll-free #: 800-603-2869
E-mail: reports@lighthouse-services.com (must refer to Alimera Sciences in the email report)

© Alimera Sciences Limited | Terms & Conditions | Privacy Policy

Date of preparation: June 2023. UK-UNB-MMM-0099
We use an analytics cookie to measure website use and to improve visitor experience. We DO NOT use marketing cookies.
By clicking here you can choose to disallow analytics. Only cookies strictly essential for the functioning of our service will remain. Privacy policy.
Date of preparation: March 2021, UK-UNB-MMM-0085